Daily Chart

Pfizer Inc. (PFE) Financial News - Skowron, Lockhart, Liquor Tax, Credit Suisse, Viagra Patent: Compliance

Pfizer Inc. (PFE)

Skowron, Lockhart, Liquor Tax, Credit Suisse, Viagra Patent: Compliance

Quote: Courts Pfizer Wins Viagra Patent-Infringement Case Against Teva Pfizer Inc. (PFE)Teva Pharmaceutical Industries Ltd. (TEVA) from marketing a generic version of the impotence drug Viagra until 2019. U.S. District Judge Rebecca Beach Smith in Norfolk, Virginia, ruled Aug. 12 against Petach Tikva, Israel-based Teva, which claimed the patent wasn’t valid and couldn’t be enforced. “Teva has not shown by clear and convincing evidence that the patent is invalid,” Smith said in a 110-page opinion. In addition, “there is utterly no evidence” to support Teva’s claim that that Pfizer intentionally withheld documents from the U.S. Patent and Trademark Office, Smith wrote. “Protecting the intellectual property rights of our innovative core is critical,” Amy Schulman, Pfizer’s general counsel, said in a statement. “Friday’s court decision acknowledges Teva’s clear violation of our patent rights.” Denise Bradley, a Teva spokeswoman, declined to comment on the ruling. “While we expect Teva to appeal, the ruling represents a clear positive for Pfizer,” said Christopher Schott, a New York-based analyst for JPMorgan Chase & Co., in a note to clients yesterday. He said the ruling is worth about 3 cents to Pfizer’s 2012 earnings per share and about 6 cents to annual earnings per share through 2019. The case is Pfizer v. Teva, 10-cv-128, U.S. District Court, Eastern District of Virginia (Norfolk). Ex-Optionable Chief Admits to Scheme to Hide Bank Losses Optionable Inc. (OPBL)Bank of Montreal. (BMO) Cassidy, 52, pleaded guilty yesterday in Manhattan federal court to one count of conspiracy to commit wire fraud. The judge set a Dec. 15 sentencing date. The case stems from C$680 million ($690.5 million) of pretax commodity-trading losses the bank announced in April 2007. Those losses grew to C$853 million for the fiscal year, paring profit by C$440 ...
Open whole article (external link)

Other Financial and Stock Market News concerning Pfizer Inc.

Pfizer Inc. Stock Summary

Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.
Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2011-2012.